Yoshimi Imaeda

Title: Innovator Yoshimi Imaeda: Pioneering Advances in Antibody Formulation

Introduction: Yoshimi Imaeda is a prominent inventor based in Tokyo, Japan, known for her significant contributions to the biotechnology field, particularly in antibody formulations. With a remarkable portfolio of seven patents, she continues to push the boundaries of innovation to create better therapeutic options.

Latest Patents: Her latest innovations include two noteworthy patents regarding high concentration antibody-containing liquid formulations. The primary aim of these patents is to provide a humanized anti-IL-6 receptor antibody formulation suitable for subcutaneous administration. Both patents focus on preventing dimerization or deamidation during long-term storage, thereby ensuring stability in a concentrated liquid formulation. Specifically, these formulations are characterized by the inclusion of arginine and histidine buffers, which play a crucial role in inhibiting deamidation or dimerization of the antibodies.

Career Highlights: Throughout her career, Yoshimi Imaeda has worked for major companies, most notably at Chugai Pharmaceutical Co., Ltd., and Hoffmann-La Roche Inc. Her work in these organizations has empowered her to develop groundbreaking solutions that have the potential to revolutionize patient care.

Collaborations: In her journey as an inventor, Yoshimi has collaborated with eminent coworkers, including Toshiyuki Morichika and Daisuke Kameoka. These partnerships have fostered a creative and innovative environment, leading to the development of her significant inventions.

Conclusion: Yoshimi Imaeda exemplifies the spirit of innovation in the field of biotechnology. Her dedication to creating effective antibody formulations emphasizes her role as a key contributor to advancing medical therapies. Through her patents, she has not only addressed critical challenges in the field but has also inspired future generations of inventors and researchers.